Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Hester Biosciences LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524669NSE Symbol: HESTERBIOP/E(TTM):43.95
ISIN Demat:INE782E01017Div & Yield %:0.47EPS(TTM):34.23
Book Value(Rs):409.0776861Market Cap ( Cr.):1279.77Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 286.47285.16254.00219.35208.48169.43
Excise Duty0.000.000.000.000.000.00
Net Sales286.47285.16254.00219.35208.48169.43
Other Income 4.764.265.324.661.652.93
Stock Adjustments -9.97-10.364.7712.53-4.0115.57
Total Income281.26279.06264.09236.54206.12187.93
EXPENDITURE :      
Raw Materials 83.7089.2884.6576.3749.3844.81
Power & Fuel Cost10.1212.349.958.746.937.29
Employee Cost 54.7656.7247.9239.1233.4537.16
Other Manufacturing Expenses 14.0714.497.576.895.466.19
Selling and Administration Expenses 54.4550.2549.2634.9432.2432.88
Miscellaneous Expenses 8.464.374.555.2610.283.95
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure225.56227.45203.88171.31137.74132.28
Operating Profit55.7151.6060.2165.2368.3755.64
Interest 5.375.096.502.473.955.03
Gross Profit50.3446.5153.7162.7664.4250.61
Depreciation8.589.789.799.509.639.39
Profit Before Tax41.7636.7343.9253.2654.7941.22
Tax11.279.6410.7314.2516.3711.81
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-1.35-0.060.86-0.51-1.48-1.80
Reported Net Profit31.8427.1632.3439.5239.9031.22
Extraordinary Items -0.350.020.010.09-3.690.38
Adjusted Net Profit32.1927.1432.3339.4343.5930.84
Adjst. below Net Profit -0.36-0.020.11-0.160.21-1.63
P & L Balance brought forward246.53226.20202.25171.40136.90113.25
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 5.106.818.518.515.625.96
P & L Balance carried down272.91246.53226.20202.25171.40136.90
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %70.0060.0080.00100.00100.0066.00
Earnings Per Share-Unit Curr37.4331.9338.0246.4546.9036.70
Earnings Per Share(Adj)-Unit Curr37.4331.9338.0246.4546.9036.70
Book Value-Unit Curr398.60367.59343.70315.54279.28238.72